Nintedanib Esylate belongs to the group of tyrosine kinase inhibitors and angiokinase inhibitors. The active ingredient slows down the formation of blood vessels, which is increasingly common in carcinomas. It is used to treat bronchial carcinomas and pulmonary fibrosis.

Pharmaceutical products
  • Nintedanib esylate
  • Nintedanib ethane sulfonate
  • 656247-18-6

Product features

Name Nintedanib Esylate
CAS Number 656247-18-6
Indication idiopathic pulmonary fibrosis
Indication 2 non-small-cell lung cancer

Need more information from the seller?